Claim Missing Document
Check
Articles

Found 2 Documents
Search

Self-Harm Inventory (SHI) Versi Indonesia Sebagai Instrumen Deteksi Dini Perilaku Self-Harm Andrian Fajar Kusumadewi; Bambang Hastha Yoga; Sumarni Sumarni; Silas Henry Ismanto
Jurnal Psikiatri Surabaya Vol. 8 No. 1 (2019): June
Publisher : Faculty of Medicine, Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (945.682 KB) | DOI: 10.20473/jps.v8i1.15009

Abstract

Background: Self-harming behavior (SHB) is an iceberg phenomenon commonly occurred in both normal population and patients with mental illness. This behavior showed an increase in trend and may develop into suicidal behavior if not treated properly. Therefore an effort in screening and prevention of self-harm is necessary to prevent early deaths caused by suicide. Currently Indonesian version of self-harm screening instrument has not been developed yet.Purpose: Conducting validity and reliability test of Indonesian version of self-harm questionnaire.Method: This research was a descriptive analytic study with cross-sectional design. We recruited 110 psychiatric outpatients from Bantul Hospital Yogyakarta (n=110). SHB was measured using Indonesian version of Self Harm Inventory (SHI). Internal validation was tested using Aiken's Validity Index (AVI) and Pearson Product Moment Correlation (PPMC). Reliability was tested using Cronbach Alpha (CA). Statistical significance was defined as p<0,05.Result: The respondents consisted of 57 men (51.8%) and 53 women (48.2%). Twenty four respondents had done more than 5 items of SHB. AVI value ranged from 0.83 to 0.97 which considered good. PPMC obtained 21 valid items with correlation coefficient >0.25 (p <0.05). Item number 22 was excluded because coefficient value was <0.25. Rresult of Keizer Meyers Oklin was 0,686 and Barlett Test of Spherecity 0,000 (p <0,05). CA was 0.831 which means very good.Conclusion: Indonesian version of Self-Harm Inventory is a valid and reliable screening tool against self-harm behavior in clinical setting.
Antipsychotic-associated neuroleptic malignant syndrome (NMS) in schizophrenia patients: a narrative review Puspita, Okta; Bambang Hastha Yoga; Zullies Ikawati
Indonesian Journal of Pharmacology and Therapy Vol 5 No 1 (2024)
Publisher : Faculty of Medicine, Public Health, and Nursing Universitas Gadjah Mada and Indonesian Pharmacologist Association or Ikatan Farmakologi Indonesia (IKAFARI)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/ijpther.9878

Abstract

Neuroleptic malignant syndrome (NMS) is a neurological disorder with an high mortality rate among schizophrenia patients who receive antipsychotics as the primary long-term therapy. Appropriate selection of antipsychotics in NMS should be carefully considered to obtain maximal effectiveness with minimal side effects. An evaluation of the safety profile of the antipsychotics is important due to their different treatment patterns and rapid onset of symptoms. This review article aimed to compare the safety profile of antipsychotics in relation to NMS in schizophrenia patients. It was a narrative review using multiple search engines included PubMed, Google Scholar, and Springer to collect publications from 2007 to 2023. Of the total 14 articles reviewed, 7 articles explained the role of antipsychotics in NMS, 5 articles about the onset of NMS, and 7 articles about mortality rate. The incidence of NMS was less then 0.11%, typical antipsychotics were the most common cause of NMS, especially high-potency antipsychotics compared with atypical antipsychotics. Meanwhile, the onset of NMS consistently occured within 30 d of antipsychotic initiation with a symptom duration of 1 to 30 d, and the mortality rate was also higher for typical antipsychotics. In conclusion, the choice of antipsychotics must be carefully considered and its use must be monitored due to the rapid onset and high mortality. The use of antipsychotics is not free from the risk of NMS. The heterogeneous symptoms of NMS require earlier detection to reduce disease progression.